Cyanotech Corporation engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. The company's products include Hawaiian BioAstin natural astaxanthin, a dietary antioxidant, which is used as a human nutraceutical and functional food ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. Cyanotech Corporation sells its products as packaged consumer products through distributors, retailers, and online channels, as well as directly to consumers; and in bulk quantities to manufacturers, formulators, and distributors. The company was founded in 1983 and is headquartered in Kailua-Kona, Hawaii.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CYAN
Previous Symbol
CUSIPN/A
Phone808-326-1353
Debt
Debt-to-Equity Ratio0.34
Current Ratio1.80
Quick Ratio0.62
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual Sales$34.12 million
Price / Sales0.61
Cash Flow$0.5153 per share
Price / Cash6.87
Book Value$2.73 per share
Price / Book1.30
Profitability
EPS (Most Recent Fiscal Year)N/A
Net Income$1.02 million
Net Margins-7.53%
Return on Equity-13.51%
Return on Assets-7.90%
Miscellaneous
Employees118
Outstanding Shares5,840,000
Market Cap$20.66 million
OptionableNot Optionable
Cyanotech (NASDAQ:CYAN) Frequently Asked Questions
What is Cyanotech's stock symbol?
Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."
How were Cyanotech's earnings last quarter?
Cyanotech Corp (NASDAQ:CYAN) announced its quarterly earnings data on Monday, November, 12th. The biotechnology company reported ($0.20) earnings per share for the quarter. The biotechnology company earned $6.95 million during the quarter. Cyanotech had a negative net margin of 7.53% and a negative return on equity of 13.51%. View Cyanotech's Earnings History.
When is Cyanotech's next earnings date?
Has Cyanotech been receiving favorable news coverage?
News articles about CYAN stock have trended very positive this week, InfoTrie Sentiment reports. The research group identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Cyanotech earned a media sentiment score of 4.0 on InfoTrie's scale. They also assigned media headlines about the biotechnology company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
Who are some of Cyanotech's key competitors?
Some companies that are related to Cyanotech include Natural Alternatives International (NAII), China Jo-Jo Drugstores (CJJD), Pharmacyte Biotech (PMCB), Mannatech (MTEX), GLG Life Tech (GLGLF), Conversion Labs (CVLB), FitLife Brands (FTLF), True Drinks (TRUU), Nutra Pharma (NPHC), Tauriga Sciences (TAUG), Entia Biosciences (ERGO), Rock Creek Pharmaceuticals (RCPIQ), Beleave (BE), Beleave (BE) and Canopy Rivers (RIV).
Who are Cyanotech's key executives?
Cyanotech's management team includes the folowing people:
- Mr. Mawae R. Morton, CEO, Pres & Director (Age 52)
- Mr. Gerald R. Cysewski Ph.D., Co-Founder, Exec. VP, Chief Scientific Officer & Vice Chairman (Age 69)
- Ms. Jole Eileen Deal, CFO, VP of Fin. & Admin., Treasurer and Corp. Sec. (Age 59)
- Mr. Gerard J. Watts, Chief Operations Officer (Age 59)
- Mr. Glenn D. Jensen, VP of Manufacturing & Infrastructure (Age 60)
Who are Cyanotech's major shareholders?
Cyanotech's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Wells Fargo & Company MN (6.48%) and FineMark National Bank & Trust (1.02%). View Institutional Ownership Trends for Cyanotech.
Which institutional investors are selling Cyanotech stock?
How do I buy shares of Cyanotech?
Shares of CYAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Cyanotech's stock price today?
One share of CYAN stock can currently be purchased for approximately $3.54.
How big of a company is Cyanotech?
Cyanotech has a market capitalization of $20.66 million and generates $34.12 million in revenue each year. Cyanotech employs 118 workers across the globe.
What is Cyanotech's official website?
How can I contact Cyanotech?
Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The biotechnology company can be reached via phone at 808-326-1353 or via email at [email protected]
MarketBeat Community Rating for Cyanotech (NASDAQ CYAN)
MarketBeat's community ratings are surveys of what our community members think about Cyanotech and other stocks. Vote "Outperform" if you believe CYAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CYAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
